Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata

Vaccine

Volumn 21, Issue 13-14, 2003, Pages 1486-1491

  Zimmerman, Richard Kent ^a,b   Raymund, Mahlon ^a   Janosky, Janine E ^a   Nowalk, Mary Patricia ^a   Fine, Michael J ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Self report; Vaccination; Validity

Indexed keywords

BACTERIAL POLYSACCHARIDE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ACCURACY; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CENTER; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT; PATIENT CARE; PATIENT SATISFACTION; POPULATION; PREDICTION; PRIORITY JOURNAL; RURAL AREA; SELF REPORT; VACCINATION;

AGED; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; PATIENT CARE; PNEUMOCOCCAL VACCINES; SENSITIVITY AND SPECIFICITY; VACCINATION;

EID: 0037471393     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00700-4     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2001;50(RR-4):1-46.
2. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
3. Jernigan D.B., Cetron M.S., Breiman R.F. Minimizing the impact of the drug-resistant Streptococcus pneumoniae (DRSP): a strategy from the DRSP working group. J. Am. Med. Assoc. 275:1996;206-209.
4. Centers for Disease Control and Prevention. Early release of selected estimates based on data from the first quarter of 2002 NHIS. http://www.cdc.gov/nchs/about/major/nhis/released200209.htm, 2002.
5. MacDonald R., Baken L., Nelson A., Nichol K.L. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am. J. Prev. Med. 16:1999;173-177.
6. Nichol K.L., Korn J.E., Baum P. Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire. Am. J. Prev. Med. 7:1991;199-203.
7. Hutchison B.G. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity, and cost. Can. J. Public Health. 80:1989;271-275.
8. Zimmerman R.K., Silverman M., Janosky J.E.et al. A comprehensive investigation of barriers to adult immunization: a methods paper. J. Fam. Pract. 50:2001;703.
9. Aday LA. Designing and conducting health surveys. San Francisco: Jossey-Bass Inc.; 1989.
10. Fukuda K., O'Mara D., Singleton J.A. How the delayed distribution of influenza vaccine created shortages in 2000 and 2001. Proc. Annu. Symp. Comput. Appl. Med. 27(5):2002;235-242.
11. Zimmerman RK, Mieczkowski TA, Janosky JE, et al. What influences older patients' influenza vaccination behavior? An analysis from inner-city, suburban, rural, and veterans affairs practices. Am J Med 2003;114(1):in press.
12. Noe C.A., Markson L.J. Pneumococcal vaccination: perceptions of primary care physicians. Prev. Med. 27:1998;767-772.
13. Mieczkowski T.A., Wilson S.A. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine. 20:2002;1383-1392.
14. Metersky M.L., Mennone J.Z., Fine J.M. Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians. Conn. Med. 62:1998;649-654.
15. Jackson L.A., Benson P., Sneller V.P. Safety of revaccination with pneumococcal polysaccharide vaccine. J. Am. Med. Assoc. 281:1999;243-244.
16. Centers for Disease Control and Prevention. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR Morb Mortal Wkly Rep 2002;51(RR-2):1-36.